These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32521002)

  • 21. Exposure to SARS-CoV-2 in a high transmission setting increases the risk of severe COVID-19 compared with exposure to a low transmission setting?
    Chen D; Hu C; Su F; Song Q; Wang Z
    J Travel Med; 2020 Aug; 27(5):. PubMed ID: 32502262
    [No Abstract]   [Full Text] [Related]  

  • 22. Segmental Pulmonary Vascular Changes in COVID-19 Pneumonia.
    Parry AH; Wani AH
    AJR Am J Roentgenol; 2020 Sep; 215(3):W33. PubMed ID: 32383969
    [No Abstract]   [Full Text] [Related]  

  • 23. Reply Letter - COVID-19 (Novel Coronavirus 2019) - Recent trends.
    Kannan S; Shaik Syed Ali Pakeer P; Sheeza Ali A; Hemalatha K
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6482-6483. PubMed ID: 32633333
    [No Abstract]   [Full Text] [Related]  

  • 24. Why is COVID-19 so mild in children?
    Brodin P
    Acta Paediatr; 2020 Jun; 109(6):1082-1083. PubMed ID: 32212348
    [No Abstract]   [Full Text] [Related]  

  • 25. Occupational exposure to Covid-19 in health personnel.
    Medina-Guillen LF
    Salud Publica Mex; 2020; 62(5):459. PubMed ID: 33027853
    [No Abstract]   [Full Text] [Related]  

  • 26. Urinalysis parameters for predicting severity in coronavirus disease 2019 (COVID-19).
    Bonetti G; Manelli F; Bettinardi A; Borrelli G; Fiordalisi G; Marino A; Menolfi A; Saggini S; Volpi R; Adamini R; Lippi G
    Clin Chem Lab Med; 2020 Aug; 58(9):e163-e165. PubMed ID: 32484450
    [No Abstract]   [Full Text] [Related]  

  • 27. COVID-19 and Eye Problems.
    Mungmunpuntipantip R; Wiwanitkit V
    Ocul Immunol Inflamm; 2020 Aug; 28(6):908. PubMed ID: 32463341
    [No Abstract]   [Full Text] [Related]  

  • 28. [Workers'health and COVID-19].
    Benavides FG
    Arch Prev Riesgos Labor; 2020 Apr; 23(2):154-158. PubMed ID: 32320540
    [No Abstract]   [Full Text] [Related]  

  • 29. Reply to "Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care".
    Ather A; Patel B; Ruparel NB; Diogenes A; Hargreaves KM
    J Endod; 2020 Sep; 46(9):1342. PubMed ID: 32810475
    [No Abstract]   [Full Text] [Related]  

  • 30. Response to: Eosinophil count in severe coronavirus disease 2019.
    Qian GQ; Zhang X; Ma AHY; Yang NB
    QJM; 2020 Jul; 113(7):513-514. PubMed ID: 32315421
    [No Abstract]   [Full Text] [Related]  

  • 31. Bleeding in COVID-19 severe pneumonia: The other side of abnormal coagulation pattern?
    Conti CB; Henchi S; Coppeta GP; Testa S; Grassia R
    Eur J Intern Med; 2020 Jul; 77():147-149. PubMed ID: 32414639
    [No Abstract]   [Full Text] [Related]  

  • 32. Nucleic acid approaches to antibody-based therapeutics for COVID-19: A perspective.
    Parzych E; Weiner DB
    J Allergy Clin Immunol; 2020 Sep; 146(3):537-540. PubMed ID: 32623068
    [No Abstract]   [Full Text] [Related]  

  • 33. Histological-ultrasonographical correlation of pulmonary involvement in severe COVID-19.
    Almeida Monteiro RA; de Oliveira EP; Nascimento Saldiva PH; Dolhnikoff M; Duarte-Neto AN;
    Intensive Care Med; 2020 Sep; 46(9):1766-1768. PubMed ID: 32494927
    [No Abstract]   [Full Text] [Related]  

  • 34. Severe coronavirus disease 2019 in children and young adults.
    Wilkes M; Issa R; Aluf A; Beliard K; Yau M; Rapaport R; Ebekozien O
    J Pediatr; 2020 Oct; 225():280. PubMed ID: 32590002
    [No Abstract]   [Full Text] [Related]  

  • 35. Interferon deficiency can lead to severe COVID.
    Meffre E; Iwasaki A
    Nature; 2020 Nov; 587(7834):374-376. PubMed ID: 33139913
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular features of IGHV3-53-encoded antibodies elicited by SARS-CoV-2.
    Fagiani F; Catanzaro M; Lanni C
    Signal Transduct Target Ther; 2020 Aug; 5(1):170. PubMed ID: 32843617
    [No Abstract]   [Full Text] [Related]  

  • 37. Early prediction of the risk of severe coronavirus disease 2019: A key step in therapeutic decision making.
    Côté A; Ternacle J; Pibarot P
    EBioMedicine; 2020 Sep; 59():102948. PubMed ID: 32810827
    [No Abstract]   [Full Text] [Related]  

  • 38. Predicting Severe Outcomes in COVID-19.
    Lipworth B; Chan R; Kuo CR
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2582-2584. PubMed ID: 32615256
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19.
    Xie Y; Cao S; Dong H; Li Q; Chen E; Zhang W; Yang L; Fu S; Wang R
    J Infect; 2020 Aug; 81(2):318-356. PubMed ID: 32283154
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibody responses in mild COVID-19 hospital staff.
    Plebani M
    EBioMedicine; 2020 Sep; 59():102940. PubMed ID: 32807702
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.